Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

We may earn a commission if you make a purchase from the links on this page. Is that bad, though? Not at all! The Galaxy S24 Plus from early 2024 was already pretty much a perfect mid-sized flagship ...

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device to empower people in improving overall health and wellness.

“Tidy dynamics and an upmarket cabin make the Mazda 3 a top-notch hatch, even if it is a bit poky” Mazda is into simplicity, on the whole. Just two petrol engines are available: a 2.5-litre ...

The event, held in Nendaz, Switzerland, combines big mountain powder skiing with backcountry freestyle. In plain English—the event organizers selected a rolling off-piste run, peppering it with ...

One lucky reader will win a pair of tickets to see Cinderella at the venue of their choice, plus an overnight stay with evening meal at a Premier Inn hotel (premierinn.com), with breakfast in the ...

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant ...

“A facelift for the Model 3 comes just in the nick of time to nudge it back ahead of rivals” There can’t be anyone who doesn’t know what a Tesla is: it’s incredible how the startup ...

Based on Lee Child’s novel Persuader, in the third season of the action-packed series, Reacher hurtles into the dark heart of a vast criminal enterprise when trying to rescue an undercover DEA ...